Form 8-K - Current report:
SEC Accession No. 0001615774-17-005634
Filing Date
2017-10-06
Accepted
2017-10-06 17:16:39
Documents
1
Period of Report
2017-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K s107708_8k.htm 8-K 11540
  Complete submission text file 0001615774-17-005634.txt   12852
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 171128064
SIC: 8731 Services-Commercial Physical & Biological Research